Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Align Technology
ALGN
|
$420M |
| 2 |
Walt Disney
DIS
|
$412M |
| 3 |
Deere & Co
DE
|
$405M |
| 4 |
Icon
ICLR
|
$400M |
| 5 |
Freeport-McMoran
FCX
|
$276M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$972M |
| 2 |
Amazon
AMZN
|
$636M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$391M |
| 4 |
Microsoft
MSFT
|
$380M |
| 5 |
Aon
AON
|
$316M |
Sector Composition
| 1 | Technology | 30.67% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Financials | 10.22% |
| 5 | Communication Services | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
BioMarin Pharmaceuticals
BMRN
$11.1B
| $305M | 0.13% |
3,948,681
-5,509
| -0.1% | -$426K |
|
|
FTCH
177
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $303M | 0.13% |
8,086,034
+2,708,880
| +50% | +$102M |
|
178
Tyler Technologies
TYL
$24.2B
| $303M | 0.13% |
660,588
-19,960
| -3% | -$9.15M |
|
179
T Rowe Price
TROW
$23.8B
| $301M | 0.13% |
1,530,970
-193,808
| -11% | -$38.1M |
|
180
Amgen
AMGN
$153B
| $300M | 0.13% |
1,411,619
-26,516
| -2% | -$5.64M |
|
181
Tesla
TSLA
$1.13T
| $297M | 0.13% |
1,149,405
+64,278
| +6% | +$16.6M |
|
182
Cimpress
CMPR
$1.54B
| $289M | 0.13% |
3,325,529
+1,567
| +0% | +$136K |
|
183
Best Buy
BBY
$16.1B
| $288M | 0.13% |
2,720,635
-115,704
| -4% | -$12.2M |
|
184
Gen Digital
GEN
$18.2B
| $284M | 0.12% |
11,219,678
+973,843
| +10% | +$24.6M |
|
185
Integra LifeSciences
IART
$1.25B
| $284M | 0.12% |
4,143,725
-499,344
| -11% | -$34.2M |
|
186
Citigroup
C
$176B
| $283M | 0.12% |
4,030,281
-1,780,563
| -31% | -$125M |
|
187
Unity
U
$18.5B
| $281M | 0.12% |
2,227,485
+1,980,428
| +802% | +$250M |
|
188
Johnson & Johnson
JNJ
$430B
| $276M | 0.12% |
1,706,144
-337,390
| -17% | -$54.5M |
|
|
XLRN
189
DELISTED
Acceleron Pharma Inc.
XLRN
| $274M | 0.12% |
1,593,352
-208,470
| -12% | -$35.9M |
|
190
NRG Energy
NRG
$28.6B
| $267M | 0.12% |
6,532,141
-815,095
| -11% | -$33.3M |
|
191
Canadian Natural Resources
CNQ
$63.2B
| $263M | 0.12% |
14,719,673
+417,844
| +3% | +$7.48M |
|
192
HP
HPQ
$27.4B
| $263M | 0.12% |
9,614,555
-4,137,342
| -30% | -$113M |
|
193
West Pharmaceutical
WST
$18B
| $261M | 0.11% |
615,863
+46,003
| +8% | +$19.5M |
|
194
Moderna
MRNA
$9.78B
| $258M | 0.11% |
670,843
-505,371
| -43% | -$195M |
|
195
Prologis
PLD
$105B
| $257M | 0.11% |
2,047,202
-278,175
| -12% | -$34.9M |
|
196
Visteon
VC
$3.41B
| $252M | 0.11% |
2,667,550
+17,470
| +0.7% | +$1.65M |
|
197
ServiceNow
NOW
$190B
| $251M | 0.11% |
403,862
-11,909
| -3% | -$7.41M |
|
198
Verisk Analytics
VRSK
$37.8B
| $250M | 0.11% |
1,249,170
-27,888
| -2% | -$5.59M |
|
|
VG
199
DELISTED
Vonage Holdings Corporation
VG
| $248M | 0.11% |
15,407,312
-6,475
| -0% | -$104K |
|
200
Mercado Libre
MELI
$123B
| $248M | 0.11% |
147,861
-11,292
| -7% | -$19M |
|